Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rainer Schulz

Showing results (71-80 of 309) with videos related to

Pageof 31
Sort By:
Free Radical Biology & Medicine|May 9, 2021
Special issue "Implications of oxidative stress and redox biochemistry for heart disease and cardioprotection - The EU-CARDIOPROTECTION COST action (CA16225)"Andreas Daiber, Ioanna Andreadou, Rainer Schulz, et al.
Basic Research in Cardiology|April 26, 2017
Physiological and therapeutic regulation of PCSK9 activity in cardiovascular diseaseSimon Glerup, Rainer Schulz, Ulrich Laufs, et al.
Basic Research in Cardiology|October 21, 2010
Inhibition of permeability transition pore opening by mitochondrial STAT3 and its role in myocardial ischemia/reperfusionKerstin Boengler, Denise Hilfiker-Kleiner, Gerd Heusch, et al.
British Journal of Pharmacology|March 19, 2016
New aspects of p66Shc in ischaemia reperfusion injury and other cardiovascular diseasesFabio Di Lisa, Marco Giorgio, Peter Ferdinandy, et al.
Frontiers in Physiology|July 21, 2022
Connexin 43 in Mitochondria: What Do We Really Know About Its Function?Kerstin Boengler, Luc Leybaert, Marisol Ruiz-Meana, et al.
Basic Research in Cardiology|June 6, 2019
P66shc and its role in ischemic cardiovascular diseasesKerstin Boengler, Julia Bornbaum, Klaus-Dieter Schlüter, et al.
Cardiovascular Research|March 1, 2015
Platelet inhibitors influence cardioprotection: importance in preclinical study design: replySandrine Lecour, Rainer Schulz, Péter Ferdinandy, et al.
European Heart Journal|March 21, 2023
Primordial non-responsiveness: a neglected obstacle to cardioprotectionGerd Heusch, Hans Erik Bøtker, Péter Ferdinandy, et al.
International Journal of Molecular Sciences|April 30, 2021
JDP2, a Novel Molecular Key in Heart Failure and Atrial Fibrillation?Gerhild Euler, Jens Kockskämper, Rainer Schulz, et al.
British Journal of Pharmacology|November 3, 2011
Glycine, a simple physiological compound protecting by yet puzzling mechanism(s) against ischaemia-reperfusion injury: current knowledgeFrank Petrat, Kerstin Boengler, Rainer Schulz, et al.
Pageof 31

Showing results (71-80 of 309) with videos related to

Sort By:
Pageof 31
Free Radical Biology & Medicine|May 9, 2021
Special issue "Implications of oxidative stress and redox biochemistry for heart disease and cardioprotection - The EU-CARDIOPROTECTION COST action (CA16225)"Andreas Daiber, Ioanna Andreadou, Rainer Schulz, et al.
Basic Research in Cardiology|April 26, 2017
Physiological and therapeutic regulation of PCSK9 activity in cardiovascular diseaseSimon Glerup, Rainer Schulz, Ulrich Laufs, et al.
Basic Research in Cardiology|October 21, 2010
Inhibition of permeability transition pore opening by mitochondrial STAT3 and its role in myocardial ischemia/reperfusionKerstin Boengler, Denise Hilfiker-Kleiner, Gerd Heusch, et al.
British Journal of Pharmacology|March 19, 2016
New aspects of p66Shc in ischaemia reperfusion injury and other cardiovascular diseasesFabio Di Lisa, Marco Giorgio, Peter Ferdinandy, et al.
Frontiers in Physiology|July 21, 2022
Connexin 43 in Mitochondria: What Do We Really Know About Its Function?Kerstin Boengler, Luc Leybaert, Marisol Ruiz-Meana, et al.
Basic Research in Cardiology|June 6, 2019
P66shc and its role in ischemic cardiovascular diseasesKerstin Boengler, Julia Bornbaum, Klaus-Dieter Schlüter, et al.
Cardiovascular Research|March 1, 2015
Platelet inhibitors influence cardioprotection: importance in preclinical study design: replySandrine Lecour, Rainer Schulz, Péter Ferdinandy, et al.
European Heart Journal|March 21, 2023
Primordial non-responsiveness: a neglected obstacle to cardioprotectionGerd Heusch, Hans Erik Bøtker, Péter Ferdinandy, et al.
International Journal of Molecular Sciences|April 30, 2021
JDP2, a Novel Molecular Key in Heart Failure and Atrial Fibrillation?Gerhild Euler, Jens Kockskämper, Rainer Schulz, et al.
British Journal of Pharmacology|November 3, 2011
Glycine, a simple physiological compound protecting by yet puzzling mechanism(s) against ischaemia-reperfusion injury: current knowledgeFrank Petrat, Kerstin Boengler, Rainer Schulz, et al.
Pageof 31